Company / EPS (Diluted)
Nuvation Bio Inc. EPS (Diluted) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$2.11
FY2025
5-year range
-$2.11 / -$0.35
FY2021-FY2025
Trend
-502.9%
vs FY2024
Sector context
#128 of 204
Health Care
What the data says
EPS (Diluted) changed -503% YoY in FY2025, a notable deviation from the 4-year average annual change of -121%.
Based on SEC 10-K filings.
-2.11 in FY2025.
Declined from $-0.35 to $-2.11 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#128 of 204 in Health CareTop 63% of 204This company -$2.11 Sector average -$0.89
▼
-135.8% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 502.9% year-over-year.
- Ranks #128 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.11 | -502.9% |
| FY2024 | -$0.35 | +0.0% |
| FY2023 | -$0.35 | +27.1% |
| FY2022 | -$0.48 | -9.1% |
| FY2021 | -$0.44 | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026